Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine vs. Alpha-Lipoic Acid in Burning Mouth Syndrome
NCT06195137Completed
- Sponsor
- Lu Jiang
- Start
- Dec 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of caffeine in burning mouth syndrome (BMS) (3 arms), sponsored by Lu Jiang. Primary endpoint: Visual Analogue Scale at 2 weeks. Started Dec 2021; status: completed.
02
Drugs
caffeine
03
Conditions
burning mouth syndrome (BMS)
Beyond the preview
Go deeper on NCT06195137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06195137.